Marvin Goldstein in Scottsdale, Arizona

Additional Medical Specialties Include:
CARDIOVASCULAR DISEASE (CARDIOLOGY)

Medical School: University Of North Carolina At Chapel Hill School Of Medicine
Graduation Year: 1965
The Primary Medical Specialty for Marvin Goldstein is listed as: Internal Medicine
Approximate Years of Experience: 59
PAC (PECOS ID)#: 0042344624
NPI #: 1881650299
NPI Created On: 04/25/2006
NPI Last Updated Listed as: 07/08/2007
Primary Taxonomy Code: 207RC0000X
License Number:
4921
Listed Gender: Male

Forms of insurance accepted by include, but are not limited to:

• Health Net of Arizona, Inc.
• Humana
• Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.

Services and Procedures include:

1. Insertion of needle into vein, patient 3 years or older
2. Insertion of needle into vein for collection of blood sample
3. Ultrasound of abdomen
4. Manual urinalysis test with examination using microscope
5. Stool analysis for blood to screen for colon tumors
6. Blood test, clotting time
7. Vaccine for influenza for injection into muscle
8. Routine ekg using at least 12 leads including interpretation and report
9. Exercise or drug-induced heart and blood vessel stress test with ekg monitoring, physician supervision, interpretation, and report
10. Heart rhythm tracing, analysis, and interpretation of 48-hour ekg
11. Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function
12. Ultrasound scanning of blood flow (outside the brain) on both sides of head and neck
13. Ultrasound study of arteries of both arms and legs
14. Measurement and graphic recording of total and timed exhaled air capacity
15. New patient office or other outpatient visit, typically 60 minutes
16. Established patient office or other outpatient visit, typically 10 minutes
17. Established patient office or other outpatient visit, typically 15 minutes
18. Established patient office or other outpatient, visit typically 25 minutes
19. Administration of influenza virus vaccine